Literature DB >> 18647612

Astrocytic control of synaptic transmission and plasticity: a target for drugs of abuse?

Philip G Haydon1, Julie Blendy, Stephen J Moss, F Rob Jackson.   

Abstract

It is well recognized that drugs of abuse lead to plastic changes in synapses and that these long-term modifications have the potential to underlie adaptive changes of the brain that lead to substance abuse. However the variety of molecular mechanisms involved in these responses are not completely defined. We are just beginning to understand some of the roles of glial cells that are associated with synapses. At many synapses an astrocyte process is associated with pre- and postsynaptic neuron processes leading to the naming of this synaptic structure as the Tripartite Synapse. Therefore, these glial cells are positioned so that they influence synaptic transmission and thus could potentially regulate the actions of some drugs of abuse. In mammalian systems there are correlations between long-term structural changes in astrocytes and responses to drugs of abuse. However, whether such changes in glia impact brain function and subsequent behaviors associated with addiction is poorly understood. Studies using Drosophila show important roles of fly glia in mediating responses to cocaine pointing to the potential for the involvement of mammalian glia in the brain's responses to this as well as other drugs. In agreement with this possibility three receptor systems known to be important in substance abuse, mGluR5, GABA(B) and CB-1 receptors, are all expressed by astrocytes and the activation of these glial receptors is now known to impact neuronal excitability and synaptic transmission. Given our new knowledge about the presence of reciprocal signaling between astrocytes and synapses we are now at a time when it becomes appropriate to determine how glial cells respond to drugs of abuse and whether they contribute to the changes in brain function underlying substance abuse.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18647612      PMCID: PMC2636575          DOI: 10.1016/j.neuropharm.2008.06.050

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  106 in total

1.  Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs.

Authors:  F E Pontieri; G Tanda; F Orzi; G Di Chiara
Journal:  Nature       Date:  1996-07-18       Impact factor: 49.962

Review 2.  Metabolic coupling between glia and neurons.

Authors:  M Tsacopoulos; P J Magistretti
Journal:  J Neurosci       Date:  1996-02-01       Impact factor: 6.167

Review 3.  Astrocytic GABA receptors.

Authors:  D D Fraser; L A Mudrick-Donnon; B A MacVicar
Journal:  Glia       Date:  1994-06       Impact factor: 7.452

4.  Direct signaling from astrocytes to neurons in cultures of mammalian brain cells.

Authors:  M Nedergaard
Journal:  Science       Date:  1994-03-25       Impact factor: 47.728

5.  Hippocampal astrocytes in situ respond to glutamate released from synaptic terminals.

Authors:  J T Porter; K D McCarthy
Journal:  J Neurosci       Date:  1996-08-15       Impact factor: 6.167

6.  A cocaine-sensitive Drosophila serotonin transporter: cloning, expression, and electrophysiological characterization.

Authors:  J L Corey; M W Quick; N Davidson; H A Lester; J Guastella
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-01       Impact factor: 11.205

7.  Cloning, expression, and localization of a chloride-facilitated, cocaine-sensitive serotonin transporter from Drosophila melanogaster.

Authors:  L L Demchyshyn; Z B Pristupa; K S Sugamori; E L Barker; R D Blakely; W J Wolfgang; M A Forte; H B Niznik
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-24       Impact factor: 11.205

8.  Involvement of N-methyl-D-aspartate receptor stimulation in the ventral tegmental area and amygdala in behavioral sensitization to cocaine.

Authors:  P W Kalivas; J E Alesdatter
Journal:  J Pharmacol Exp Ther       Date:  1993-10       Impact factor: 4.030

9.  Glutamate-mediated astrocyte-neuron signalling.

Authors:  V Parpura; T A Basarsky; F Liu; K Jeftinija; S Jeftinija; P G Haydon
Journal:  Nature       Date:  1994-06-30       Impact factor: 49.962

10.  D-serine, an endogenous synaptic modulator: localization to astrocytes and glutamate-stimulated release.

Authors:  M J Schell; M E Molliver; S H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-25       Impact factor: 11.205

View more
  51 in total

Review 1.  New medications for drug addiction hiding in glutamatergic neuroplasticity.

Authors:  P W Kalivas; N D Volkow
Journal:  Mol Psychiatry       Date:  2011-04-26       Impact factor: 15.992

Review 2.  Adenosine and glutamate signaling in neuron-glial interactions: implications in alcoholism and sleep disorders.

Authors:  Hyung W Nam; Sally R McIver; David J Hinton; Mahesh M Thakkar; Youssef Sari; Fiona E Parkinson; Phillip G Haydon; Doo-Sup Choi
Journal:  Alcohol Clin Exp Res       Date:  2012-02-06       Impact factor: 3.455

Review 3.  The "toll" of opioid-induced glial activation: improving the clinical efficacy of opioids by targeting glia.

Authors:  Linda R Watkins; Mark R Hutchinson; Kenner C Rice; Steven F Maier
Journal:  Trends Pharmacol Sci       Date:  2009-09-15       Impact factor: 14.819

Review 4.  Glial cell modulation of circadian rhythms.

Authors:  F Rob Jackson
Journal:  Glia       Date:  2010-12-01       Impact factor: 7.452

Review 5.  Glial and Neuroimmune Mechanisms as Critical Modulators of Drug Use and Abuse.

Authors:  Michael J Lacagnina; Phillip D Rivera; Staci D Bilbo
Journal:  Neuropsychopharmacology       Date:  2016-07-11       Impact factor: 7.853

6.  Aquaporin-4 deficiency impairs synaptic plasticity and associative fear memory in the lateral amygdala: involvement of downregulation of glutamate transporter-1 expression.

Authors:  Yan-Kun Li; Fang Wang; Wei Wang; Yi Luo; Peng-Fei Wu; Jun-Li Xiao; Zhuang-Li Hu; You Jin; Gang Hu; Jian-Guo Chen
Journal:  Neuropsychopharmacology       Date:  2012-04-04       Impact factor: 7.853

Review 7.  Glial modulators as potential treatments of psychostimulant abuse.

Authors:  Patrick M Beardsley; Kurt F Hauser
Journal:  Adv Pharmacol       Date:  2014

Review 8.  An essential role for adenosine signaling in alcohol abuse.

Authors:  Christina L Ruby; Chelsea A Adams; Emily J Knight; Hyung Wook Nam; Doo-Sup Choi
Journal:  Curr Drug Abuse Rev       Date:  2010-09

Review 9.  Glial-neuronal interactions--implications for plasticity and drug addiction.

Authors:  Sukumar Vijayaraghavan
Journal:  AAPS J       Date:  2009-02-24       Impact factor: 4.009

10.  Dorsal hippocampal neural immune signaling regulates heroin-conditioned immunomodulation but not heroin-conditioned place preference.

Authors:  Jacqueline E Paniccia; Christina L Lebonville; Meghan E Jones; Shveta V Parekh; Rita A Fuchs; Donald T Lysle
Journal:  Brain Behav Immun       Date:  2018-07-31       Impact factor: 7.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.